Coronary perforation is an uncommon yet potentially fatal complication associated with percutaneous coronary intervention (PCI). Distal wire perforations may rapidly lead to cardiac tamponade and hemodynamic collapse if not promptly recognised and treated. The Study reports a cas...
Open access
Research Article10.9734/ajcr/2026/v9i1375
Drug-coated balloons (DCBs) have emerged as an established alternative to drug-eluting stents (DES) in selected coronary settings, particularly for in-stent restenosis and small vessel disease. Their role in de novo coronary lesions during the acute phase of ST-elevation myocardi...
Open access
Research Article10.9734/ajcr/2026/v9i1374
Background: Paragangliomas are rare catecholamine-secreting neuroendocrine tumors that can cause severe cardiovascular manifestations, including the uncommon presentation of Takotsubo cardiomyopathy mimicking acute coronary syndrome. Aims: To report a rare case of retroperitoneal...
Open access
Research Article10.9734/ajcr/2026/v9i1373
Dilated cardiomyopathy (DCM) is a heterogeneous myocardial disorder frequently linked to ischemic, hypertensive, or idiopathic etiologies. However, metabolic causes such as hypocalcemia, though rare, can lead to reversible myocardial dysfunction. Hypocalcemia-induced cardiomyopat...
Open access
Research Article10.9734/ajcr/2026/v9i1372
Background: Ebstein’s anomaly is frequently associated with complex arrhythmogenic substrates, particularly multiple accessory pathways and concealed intrinsic conduction abnormalities. However, preservation of native right-sided conduction following successful accessory pathway...
Open access
Research Article10.9734/ajcr/2026/v9i1371
Background: Wolff–Parkinson–White (WPW) syndrome is a cardiac conduction disorder characterized by the presence of an accessory atrioventricular pathway responsible for ventricular pre-excitation and predisposition to supraventricular tachyarrhythmias. Although frequently diagnos...
Open access
Research Article10.9734/ajcr/2026/v9i1370
Antiplatelet therapy forms the cornerstone of pharmacological management following percutaneous coronary intervention (PCI) in patients with acute coronary syndrome (ACS). For decades, dual antiplatelet therapy (DAPT) — conventionally comprising aspirin combined with a P2Y12 rece...
Open access
Research Article10.9734/ajcr/2026/v9i1367
Introduction: Heart failure with reduced ejection fraction (HFrEF), defined as LVEF ≤ 40%, is a major public health problem due to its high morbidity and mortality, affecting approximately 64.3 million individuals worldwide, of whom nearly 50% present with reduced ejection fracti...
Open access
Research Article10.9734/ajcr/2026/v9i1368
Background: The rare cardiac involvement of neuroendocrine tumors (NETs), uncommon neoplasms with neuroendocrine differentiation that typically arise in the gastroenteropancreatic and pulmonary systems but may present with constitutional symptoms, arrhythmias, thromboembolic even...
Open access
Research Article10.9734/ajcr/2026/v9i1369
Background: Lipoprotein A is a genetically determined low-density lipoprotein like particle bound covalently to apolipoprotein. It is increasingly recognized as a highly atherogenic and prothrombotic molecule, contributing to the development and progression of atherosclerotic car...
Open access
Research Article10.9734/ajcr/2026/v9i1365